drugset / Trial / NCT01263808
Cardiac Safety of Indacaterol
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study compares the cardiac safety of inhaled indacaterol with that of placebo and oral moxifloxacin.
Timeline
- Start
- 2008-04
- Primary completion
- 2008-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indacaterol | Other / unclassified | 150 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 300 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 600 ug | Inhaled |
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |